Diuretic Resistance Study for Heart Failure

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3

Recruiting Phase 1 Interventional Study
Heart Failure Diuretic Resistance
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Other
Participants needed
50 (estimated)
Sponsor
Yale University · Other
Who this trial is looking for

This trial is looking for people with heart failure who have trouble responding to diuretics. Participants will take part in a study to understand how diuresis resistance works and will receive treatments in a crossover manner.

Are You a Good Fit for This Trial?
Rules you out Liver failure

You may be able to join if

  • I have been diagnosed with heart failure.
  • I am over 18 years old.
  • I have not been hospitalized in the last 2 months.
  • I have stable symptoms and weight.
  • My potassium level is 5.0 mmol/L or lower.
  • My sodium level is 130 mEq/L or higher.
  • My hemoglobin is 8 g/dL or higher.
  • I have objective evidence of diuretic resistance.

You may not be able to join if

  • My GFR is lower than 20 ml/min.
  • I have had any non-loop diuretic in the last 7 days.
  • I have a history of flash pulmonary edema.
  • My hemoglobin is lower than 8 g/dL.
  • I am pregnant or breastfeeding.
  • I have liver disease or cirrhosis.
  • I have a history of metabolic or respiratory acidosis in the last 30 days.
  • I cannot give informed consent or follow the study protocol.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Randomized double-blind placebo-controlled crossover study design

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of heart failure * No plan for titration/change of heart failure medical or device therapies during the study period. * Absence of non-elective hospitalizations in the previous 2 months. * At optimal volume status by symptoms, exam, and dry weight. * Serum p…
Contacts

Veena Rao, PHD

2037373571

veena.s.rao@yale.edu

CONTACT